Proposta di Green Pass della Commissione Europea
https://youtu.be/hpWih9AzuRU

"We have recently discovered that UK laboratories have been routinely recording a significant proportion of Covid-19 test results as positive based on the presence of one target gene alone, when there should have been two or more, as required to comply with WHO rules and manufacturer instructions. Without diagnostic validation, for both the original virus and any variants, it is not clear what can be concluded from a positive test resulting from a single target gene call, especially if there was no confirmatory testing. Given this, many of the reported positive results may be inconclusive, negative or from people who suffered past infection for SARS-COV-2"
http://probabilityandlaw.blogspot.com/2021/02/uk-lighthouse-laboratories-testing-for.html?m=1

"As early as April 2020, the UK lighthouse laboratories were testing for single genes and discounted the S gene as early as mid-May [10], months before the discovery of the new variant B1.1.7. Indeed, in Table 1 of [10] 18% of tests were positive on one gene only. Furthermore, in a Public Health England report on variants [2] published 8 January 2021, it states the goal of using one gene was explicitly to approximate the growth of the new B1.1.7 variant:
“There has recently been an increase in the percentage of positive cases where only the ORF1ab- and N-genes were found and a decrease in the percentage of cases with all three genes. We can use this information to approximate the growth of the new variant.”
Section 10 of this ONS Covid-19 Infection Survey report [11] on 8 January 2021 confirms that one gene is sufficient for a positive result.
Obviously, there is a higher risk of encountering false positives when testing for single genes alone, because of the possibility of cross-reactivity with other human coronaviruses (HCOVs) as well as prevalent bacteria or reagent contamination. The potential for cross reactivity has already been confirmed by the German Instand laboratory report from April 2020 [12] (note that Prof. Drosten, co-author of Corman et al [2] is a cooperating partner listed in this report). The report describes the systematic blind testing of positive and negative samples anonymously sent to 463 laboratories from 36 countries and evaluated for the presence of a variety of genes associated with SARS-COV-2. They reported significant cross reactivity and resultant false positives for OC43, and HCoV 229E (a common cold virus) as well as for SARS-COV-2 negative samples, not containing any competing pathogen. Likewise, 70 Dutch laboratories were surveyed in November 2020, by the National Institute for Public Health and the Environment [13], with 76 diagnostic workflows reported as using only one target gene to diagnose the presence of SARS-COV-2 (46% of all workflows).
Without diagnostic validation it is not clear what can be concluded from a positive PCR test resulting from a single target gene call, especially if there was no confirmatory testing. Many of the reported positive results may be inconclusive, negative or from people who suffered past infection for SARS-COV-2. Even with diagnostic validation of the single target gene call, the UK lighthouse laboratories appear not to be in strict conformance with the WHO emergency use assessment and the manufacturer instructions for use. Given this it is clear the ONS and the UK lighthouse laboratories needs to publicly clarify their use of, and justify the reasons for, deviating from these standards."
https://www.bmj.com/content/372/bmj.n208/rr-3

ACTION: PLEASE SHARE THIS VIDEO ON ALL YOUR PLATFORMS IF YOU LIVE IN OR NEAR THE EUROPEAN UNION

Green Pass proposal from the European Commission
https://youtu.be/V8iwknDwO2s

A lot of what I shared today is also on twitter on this account as my main one is suspended
https://twitter.com/robinmonottibot/status/1372875213722038278?s=19

2014 "Intravenous injection of a variety of nanotechnology enhanced (liposomal, micellar, polymer-conjugated) and protein-based (antibodies, enzymes) drugs can lead to hypersensitivity reactions (HSRs), also known as infusion, or anaphylactoid reactions. The molecular mechanism of mild to severe allergy symptoms may differ from case to case and is mostly not known, however, in many cases a major cause, or contributing factor is activation of the complement (C) system. The clinical relevance of C activation-related HSRs, a non-IgE-mediated pseudoallergy (CARPA), lies in its unpredictability and occasional lethal outcome."

Complement activation-related pseudoallergy: A stress reaction in blood triggered by nanomedicines and biologicals - ScienceDirect
https://www.sciencedirect.com/science/article/abs/pii/S0161589014001692?via%3Dihub

They are all Vazis

(Extremist Vaccine Nationalists who believe in the inherent superiority of the vaccinated as the new transhumanist Aryans).

You don't reason with Vazis.

You defeat them on all fronts.

You take their Reichstags.

"Vaccines" are the opium of the masses.

Furlough is the opium of the UK masses

Vaccine passports are the rope the masses will gladly accept around their necks so that the oligarchs can then pull the rope and hang them with it at their liking.

That's the problem with lockdowns, so many people don't understand the damage it can do. Many on furlough earning 80% of their salary by doing nothing that can't recognise the issue for those who are unemployed.

The Green Pass proposal from the European Commission is the rope European Union citizens and residents will be hanged with. Now is the time to say No. Now is the time for demonstrations. Or rather literally tomorrow is the time: 20th March 2021 needs to make history.
https://youtu.be/V8iwknDwO2s

"In this review, we discuss the possible underlying mechanisms of autoimmune reactions following vaccinations and review cases of autoimmune diseases that have been correlated with vaccination. Molecular mimicry and bystander activation are reported as possible mechanisms by which vaccines can cause autoimmune reactions. The individuals who might be susceptible to develop these reactions could be especially not only those with previous post-vaccination phenomena and those with allergies but also in individuals who are prone to develop autoimmune diseases, such as those with a family history of autoimmunity or with known autoantibodies, and the genetic predisposed individuals."

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5607155/

French speakers, please become familiar with this site:
https://notrebondroit.be/action-pass-vaccinal

OPEN LETTER TO ALL MEMBERS OF THE EUROPEAN PARLIAMENT ON THE EUROPEAN COMMISSION'S GREEN PASS PROPOSAL
https://t.me/robinmg/1555

I posted this one before but I’m not you have noticed it. It’s a really good paper. They are doing a meta analysis of known scientific potential issues on mid and long term after vaccination. And it’s in regard to Covid 19 also.
They identified no less that 16 major issues that can occur on mid & long term after vaccination.

“3.4. Vaccine mechanisms with uncertain consequences
Numerous mid- and longer-term potential issues concerning vaccines have been identified. Their themes are summarized initially, followed by excerpts from specific cited references.
1)
Antibody-Dependent Enhancement (where enhanced virus entry and replication in a number of cell types is enabled by antibodies) [[47], [48], [49], [50], [51], [52], [53], [54]];
-1a)
Intrinsic Antibody-Dependent Enhancement (where non-neutralizing antibodies raised by natural infection with one virus may enhance infection with a different virus) [[55], [56], [57], [58], [59], [60], [61]];
-1b)
Immune Enhancement (enhancement of secondary infections via immune interactions) [[62], [63], [64], [65]];
-1c)
Cross-reactivity (an antibody raised against one specific antigen has a competing high affinity toward a different antigen.) [66,67]
-1d)
Cross-Infection Enhancement (infection enhancement of one virus by antibodies from another virus) [68,69]
2)
Vaccine-associated Virus Interference (where vaccinated individuals may be at increased risk for other respiratory viruses because they do not receive the non-specific immunity associated with natural infection) [[70], [71], [72], [73], [74], [75]];
3)
Vaccine-Associated Imprinting Reduction (where vaccinations could also reduce the benefits of ‘imprinting’, a protection conferred upon children who experienced infection at an early age) [76,77];
4)
Non-Specific Vaccine Effects on Immune System (where previous infections can alter an individual's susceptibility to unrelated diseases) [78,79];
5)
Impact of Infection Route on Immune System (where immune protection can be influenced by the route of exposure/delivery) [[80], [81], [82]];
6)
Impact of Combinations of Toxic Stimuli (where people are exposed over their lifetime to myriad toxic stimuli that may impact the influence of any vaccine) [78; 83, 84];
7)
Antigenic Distance Hypothesis (negative interference from prior season’s influenza vaccine (v1) on the current season’s vaccine (v2) protection may occur when the antigenic distance is small between v1 and v2 (v1 ≈ v2) but large between v1 and the current epidemic (e) strain (v1 ≠ e).) [[85], [86], [87]];
8)
Bystander Activation (activation of T cells specific for an antigen X during an immune response against antigen Y) [[88], [89], [90]];
9)
Gut Microbiota (Impact of gut microbial composition on vaccine response) [[91], [92], [93], [94], [95]];
10)
Homologous Challenge Infection Enhancement (the strain of challenge virus used in the testing assay is very closely related to the seed virus strain used to produce the vaccine that a subject received) [[96], [97], [98]];
11)
Immune Evasion (evasion of host response to viral infection) [[99], [100], [101], [102]];
12)
Immune Interference (interference from circulating antibody to the vaccine virus) [103,104];
­
12a) Original antigenic sin (propensity of the body's immune system to preferentially utilize immunological memory based on a previous infection when a second slightly different version of that foreign entity (e.g. a virus or bacterium) is encountered.) [[105], [106], [107], [108]];
13)
Prior Influenza Infection/Vaccination (effects of prior influenza infection/vaccination on severity of future disease symptoms) [[109], [110], [111], [112], [113], [114], [115], [116]];
14)
Timing between Viral Exposures (elapsed time between viral exposures) [[117], [118], [119], [120]];
15)
Vaccine-Associated Enhanced Respiratory Disease (where vaccination enhances respiratory disease) [[121], [122], [123]];
16)
Chronic Immune Activation (continuous innate immune responses) [[124], [125], [126]].
https://www.sciencedirect.com/science/article/pii/S2214750020304248

This one is also important. WHO advises against travel passports.

WHO: Interim position paper: considerations regarding proof of COVID-19 vaccination for international travellers
“At the present time, it is WHO’s position that national authorities and conveyance operators should not introduce requirements of proof of COVID-19 vaccination for international travel as a condition for departure or entry, given that there are still critical unknowns regarding the efficacy of vaccination in reducing transmission. In addition, considering that there is limited availability of vaccines, preferential vaccination of travellers could result in inadequate supplies of vaccines for priority populations considered at high risk of severe COVID-19 disease. WHO also recommends that people who are vaccinated should not be exempt from complying with other travel risk-reduction measures.”

“Scientific considerations
A number of scientific unknowns remain concerning the effectiveness of COVID-19 vaccines: efficacy in preventing disease and limiting transmission, including for variants of SARS-CoV-2; duration of protection offered by vaccination; timing of booster doses; whether vaccination offers protection against asymptomatic infection; age and population groups that should be prioritized for vaccination, specific contraindications, how long before travel vaccines should be offered; and possible exemption of people who have antibodies against SARS-CoV-2.”

https://www.who.int/news-room/articles-detail/interim-position-paper-considerations-regarding-proof-of-covid-19-vaccination-for-international-travellers

World Wide Demonstrations March 20th 2021 - Livestreams
https://worldwidedemonstration.com/livestreams/